InnoTherapy Inc (246960) — Cash Flow Reinvestment Rate
Latest as of June 2025:
25.57x
InnoTherapy Inc (246960) has a Cash Flow Reinvestment Rate of 25.57x as of June 2025, reinvesting ₩3.35 Billion (capex ₩367.29 Million plus investments ₩2.98 Billion) from operating cash flow of ₩131.12 Million. Check 246960 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
25.57x
(Capex + Investments) / Operating CF
Total Reinvested
₩3.35 Billion
Capex + Investments
Operating Cash Flow
₩131.12 Million
KRW
Capital Expenditures
₩367.29 Million
KRW
Annual Cash Flow Reinvestment Rate for InnoTherapy Inc (None–None)
Year-by-year capital reinvestment analysis for InnoTherapy Inc. For live market cap and broader valuation context, see InnoTherapy Inc (246960) total market value.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow